Cell and gene therapy (CGT) developers can encounter numerous challenges in bringing their products to market, so they often enlist a contract development and manufacturing organization (CDMO) to help them through the process. Some CDMOs however, have long lead times for limited production slots, use complex manufacturing platforms that lack scalability, and can generate products that fail to meet quality standards.

CoJourney has a strong track record of success in CGT development and manufacturing. Their optimized platform shortens timelines, lowers costs, and consistently delivers high quality product. Our services support the development, cGMP manufacturing, and analytical testing of plasmids, viral vectors, and mRNA produced in our state-of-the-art manufacturing facilities that meet FDA, EMA, and NMPA guidelines.